Wen‐Yu Chang

A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C

Ming‐Lung Yu, CY Dai, Jee‐Fu Huang et al. · Gut · 2006 · 285 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial

Ming‐Lung Yu, Chia‐Yen Dai, Jee‐Fu Huang et al. · Hepatology · 2008 · 278 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

A Sustained Virological Response to Interferon or Interferon/Ribavirin Reduces Hepatocellular Carcinoma and Improves Survival in Chronic Hepatitis C: A Nationwide, Multicentre Study in Taiwan

Ming‐Lung Yu, Shi‐Ming Lin, Wan‐Long Chuang et al. · Antiviral Therapy · 2006 · 183 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17

Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients

Ming‐Lung Yu, Chung‐Feng Huang, Jee‐Fu Huang et al. · Hepatology · 2010 · 179 citations · Full text

Medicine, Infectious Diseases, Molecular Genetics +17

Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients

Chia‐Yen Dai, Jee‐Fu Huang, Ming‐Yen Hsieh et al. · Journal of Hepatology · 2009 · 146 citations

Medicine, Endocrinology, Pharmacology +15